Patents & Intellectual Property
Building a robust IP portfolio to protect breakthrough innovations in longevity science while advancing human health through strategic patent development.
Patent Portfolio Overview
Our intellectual property strategy encompasses multiple areas of innovation, with over 6 patents filed or in preparation across reprogramming technologies and natural compound synthesis methods.
Reprogramming Technologies
Multiple patents filed covering novel approaches to cellular reprogramming for cancer treatment, including targeted methods for glioblastoma and dual-factor techniques for restoring normal cellular function.
Natural Compound Synthesis
Through strategic partnerships, we have filed patents for high-efficiency synthesis methods of beneficial compounds including flavonoid derivatives and proanthocyanidins, with applications in therapeutics and consumer health.
Areas of Innovation
Cancer Reprogramming
Novel approaches to reprogram cancer cells, particularly targeting brain cancers with engineered transcription factors
Synthesis Methods
High-efficiency production methods for therapeutic compounds including advanced proanthocyanidin synthesis
Applied Formulations
Consumer health applications including enhanced formulations for hair growth and other wellness products
Filing Status
Reprogramming Patents
Under review
Joint Venture Patents
Filed or granted
In Development
2025-2026 pipeline
Our IP Strategy
Defensive Portfolio
Protecting our core innovations while maintaining freedom to operate in the rapidly evolving longevity space.
Strategic Partnerships
Collaborating with research institutions and industry partners to develop comprehensive IP coverage across multiple therapeutic areas.
Global Coverage
Filing in key markets worldwide to ensure our innovations can benefit patients globally while protecting our competitive advantage.
Responsible Innovation
Balancing IP protection with our commitment to advancing the field of longevity science for the benefit of humanity.